Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by AvPAK, priced at $0.0900 per EA under NDC 50268032613. Its NADAC has been published 142 times since Dec 6, 2023.
FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
AvPAKNDC
50268032613
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207057FDA Approved
10/26/2017
TE Code
AB1
On Market Since
8/8/2023
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 142 times since Dec 6, 2023, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0900 per EA |
|---|---|
| All-time high | $0.1275 (Jan 10, 2024) |
| All-time low | $0.0799 (Nov 20, 2024) |
| 52-week high | $0.1016 |
| 52-week low | $0.0900 |
| Median price | $0.1017 |
| Average price | $0.1039 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Dec 6, 2023 |
1W
N/A
1M
N/A
3M
-6.5%
6M
-9.3%
1Y
-11.4%
3Y
N/A
5Y
N/A
All
-26.2%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Gabapentin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by AvPAK, is $0.0900 per EA (NDC 50268032613), effective Aug 19, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 26.2%. It has been tracked across 142 weekly CMS publications since Dec 6, 2023.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Dec 6, 2023, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1275 (Jan 10, 2024), with a median of $0.1017 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 800 MG TABLET, is $0.0883 per EA — about 2% below GABAPENTIN 800 MG TABLET.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 50268032613) is labeled by AvPAK, and CMS classifies it as a generic product.